Lifestyle and advanced glycation end products (AGEs) burden: Its relevance to healthy aging

Aging and Disease

Volumn 5, Issue 3, 2014, Pages 212-217

  Prasad, Chandan ^a   Imrhan, Victorine ^a   Marotta, Francesco ^b   Juma, Shanil ^a   Vijayagopal, Parakat ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

^b ReGenera Research Group for Aging Intervention   (Italy)

Author keywords

Aging; Glycation; Oxidative stress; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

EID: 84908206562     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500212     Document Type: Review

References (39)

1. Salganik RI (2001). Apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr, 20:464S-472S.
2. Halliwell B, Cutteridge JMC (1969). Free radicals in biology and medicine. Oxford: Oxford University Press.
3. Aims BN, Shinegava MK, Hagen TM (1993). Oxidants, antioxidants and the degenerative diseases. Proc Natl Acad Sci USA, 90:7915-7922.
4. Kerr JFR, Winterfold CM, Harmon BV (1994). Apoptosis, its significance in cancer and cancer therapy. Cancer, 73:2013-2026.
5. Blackstone NW, Green DR (1999). The evolution of a mechanism of cell suicide. BioEssays, 21:84-88.
6. Ghosh MK, Mukhopadhyay M, Chatterjee IB (1997). NADPH-initiated P450-dependent free-iron-dependent microsomal lipid peroxidation: specific prevention by ascorbic acid. Mol Cell Biochem, 166:35-44.
7. Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA (2011). RAGE biology, atherosclerosis and diabetes. Clin Science, 121:43-55.
8. Kalousová, M, Zima, T, Tesar V, Dusilová-Sulková S, Jan Škrha J (2005). Advanced glycooxidation end products in chronic disease-clinical chemistry and genetic background. Mutation Res, 579: 37-46.
9. Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L (2010). Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol, 108: 109-115.
10. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. J of the Am Diet Assoc, 110: 911-916.
11. Maillard LC (1912). Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C R Acad Sci (Paris) 154:66-68.
12. Luevano-Contreras C, Chapman-Novakofski K (2010). Dietary Advanced Glycation End Products and Aging. Nutrients 2: 1247-1265.
13. Prasad A, Bekker P, Tsimikas S (2012). Advanced glycation end products and diabetic cardiovascular disease. Cardiol Rev 20:177-183.
14. Willett TL, Kandel R, De Croos JNA, Avery NC, MGrynpas MD (2012). Enhanced levels of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression. Osteoarthritis Cartilage 20: 7736-744.
15. Ulrich P, Cerami A (2001). Protein glycation, diabetes, and aging. Recent Prog Horm Res, 56:1-21.
16. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT (2009). RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation. J Transl Med, 17: 7-17.
17. Ramasamy R, Vannucci SJ, Shi Du Yan S, Herold K, Fang Yan S, Schmidt AM (2005). Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology, 15 (7):16R-28R.
18. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME (2008). A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J, 22:3716-3727.
19. Kalea AZ, Schmidt AM, Hudson BI (2011). Alternative splicing of RAGE: roles in biology and disease. Frontiers in Bioscience, l16: 2756-2770.
20. Ramasamy R, Yan S-F, Schmidt AM (2012). Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids, 42(4): 1151-1161.
21. Fritz G (2011). RAGE a single receptor fits multiple ligands. Trends in Biochem Sci, 36(12):625-632.
22. Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J (2009). Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: Role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab, 94:4483-4491.
23. Vlassara H, Striker G (2007). Glycotoxins in the diet promote diabetes and diabetic complications. Curr. Diab Rep, 7:235-241.
24. Peppa M, Uribarri J, Vlassara H (2008). Aging and glycoxidant stress. Hormones (Athens), 7:123-132.
25. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., Vlassara H (2007). Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J. Gerontol. A Biol Sci Med Sci, 62:427-433.
26. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, Artini PG, Piomboni P, Focarelli R (2008). Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update, 14:131-142.
27. Tatone C, Carbone MC, Campanella G, Festuccia C, Artini PG, Talesa V, Focarelli R, Amicarelli F (2010). Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively-aged mice. J Biol Regul Homeost Agents, 24:63-72.
28. Lindeman R.D (1990). Overview: Renal physiology and pathophysiology of aging. Am J Kidney Dis, 16:275-282.
29. Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H (2002). Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes, 51:2082-2089.
30. Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H (2002). Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev, 18:224-237.
31. Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H (2003). Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes, 52:1441-1448.
32. Sebekova K, Hofmann T, Boor P, Sebekova K, Jr, Ulicna O, Erbersdobler HF, Baynes JW, Thorpe SR, Heidland A, Somoza V (2005). Renal effects of oral maillard reaction product load in the form of bread crusts in healthy and subtotally nephrectomized rats. Ann N Y Acad Sci, 1043:482-491.
33. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, Papavassiliou AG (2007). Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med, 85:1413-1420.
34. Bengmark S (2006). Impact of nutrition on ageing and disease. Curr Opin Clin Nutr Metab Care, 9:2-7.
35. Davis K, Prasad C, Juma S, Vijayagopal P, Imrhan V (2013). Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain? Critical Reviews in Nutrition and Food Science (In Press).
36. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, Vlassara H (2004). Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc, 104:1287-1291.
37. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc, 110:911-16.
38. Nicholl ID, Bucala R (1998). Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand), 44(7):1025-33.
39. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, Cerami A (1997). Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A, 94(25):13915-20.